PHILLIPS CHARLES G III 4

Accession 0001209191-19-033629

CIK 0001645113other

View on SEC.gov Company Profile

Filed

May 30, 8:00 PM ET

Accepted

May 31, 4:11 PM ET

Size

26.3 KB

Accession

0001209191-19-033629

Insider Transaction Report

Form 4

Period: 2019-05-29

NovoCure LtdNVCR

PHILLIPS CHARLES G III

Director

Transactions

Exercise/Conversion
Options to Buy Ordinary Shares
2019-05-29−50,000→ 62,607 total
Exercise: $6.72Exp: 2022-09-28→ Ordinary Shares (50,000 underlying)
Exercise/Conversion
Options to Buy Ordinary Shares
2019-05-29−23,600→ 0 total
Exercise: $12.30From: 2018-05-10Exp: 2027-05-09→ Ordinary Shares (23,600 underlying)
Exercise/Conversion
Ordinary Shares
2019-05-29$6.72/sh+50,000$336,000→ 59,504 total
Sale
Ordinary Shares
2019-05-29$52.09/sh−47,080$2,452,303→ 12,424 total
Sale
Ordinary Shares
2019-05-29$52.84/sh−2,920$154,304→ 9,504 total
Exercise/Conversion
Ordinary Shares
2019-05-29$11.39/sh+21,500$244,885→ 31,004 total
Sale
Ordinary Shares
2019-05-29$52.09/sh−16,326$850,356→ 14,678 total
Sale
Ordinary Shares
2019-05-29$52.96/sh−5,174$274,020→ 9,504 total
Exercise/Conversion
Ordinary Shares
2019-05-29$12.30/sh+23,600$290,280→ 33,104 total
Sale
Ordinary Shares
2019-05-29$52.08/sh−22,200$1,156,265→ 10,904 total
Sale
Ordinary Shares
2019-05-29$52.82/sh−1,400$73,949→ 9,504 total
Exercise/Conversion
Options to Buy Ordinary Shares
2019-05-29−21,500→ 0 total
Exercise: $11.39From: 2017-05-04Exp: 2026-05-04→ Ordinary Shares (21,500 underlying)

Footnotes (7)

[F1]On May 29, 2019, Mr. Phillips sold 47,080 shares in multiple trades at prices ranging from $51.62 to $52.61. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F2]On May 29, 2019, Mr. Phillips sold 2,920 shares in multiple trades at prices ranging from $52.64 to $53.06. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F3]On May 29, 2019, Mr. Phillips sold 16,326 shares in multiple trades at prices ranging from $51.57 to $52.56. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F4]On May 29, 2019, Mr. Phillips sold 5,174 shares in multiple trades at prices ranging from $52.58 to $53.30. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F5]On May 29, 2019, Mr. Phillips sold 22,200 shares in multiple trades at prices ranging from $51.63 to $52.61. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F6]On May 29, 2019, Mr. Phillips sold 1,400 shares in multiple trades at prices ranging from $52.63 to $52.96. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
[F7]Options to buy 50,000 ordinary shares are vested and currently exercisable as of the date hereof.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NovoCure Ltd

CIK 0001645113

→

Entity typeother

Related Parties

filerCIK 0001129246

Filing Metadata

Form type: 4
Filed: May 30, 8:00 PM ET
Accepted: May 31, 4:11 PM ET
Size: 26.3 KB

View on SEC.gov